Delta Neutrophil Index and Neutrophil Lymphocyte Ratio in Thyroid Malignancy
Primary Purpose
Thyroid Cancer, Thyroid Nodule, Thyroid Diseases
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Complete Blood Count
Sponsored by
About this trial
This is an interventional diagnostic trial for Thyroid Cancer focused on measuring Delta neutrophyl index, Immature granulocyte count, Thyroid Cancer, Thyroid Nodule, Neutrophyl to lymphocyte ratio
Eligibility Criteria
Inclusion Criterias:
- Operated thyroid malignancy patients (Total thyrodectomy, complementary thyroidectomy)
- Operated benign thyoridal goitor patients
- Selectively operated inguinal hernia patients without any concomitant malignancy
- Selectively operated inguinal hernia patients without any thyroid disorder
Exclusion Criterias:
- Patients undergoing emergent surgery
- Patients with concomitant rheumatologic disease undergoing thyroid surgery in selective conditions
- Patients with concomitant rheumatologic disease undergoing inguinal hernia operation in selective conditions
- Patients with concomitant thyroid disease undergoing inguinal hernia operation in selective conditions
- Patients with concomitant any malignancy undergoing inguinal hernia operation in selective conditions
- Patients whose data were not available or were missing.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Active Comparator
Sham Comparator
Other
Arm Label
Thyroid Malignancy
Benign Thyroidal Goitor
Control Group
Arm Description
Thyroidectomy
Thyroidectomy
Selective lichtenstein procedure for inguinal hernia
Outcomes
Primary Outcome Measures
Delta neutrophyl index for thyroid malignancies
The correlation between DNI and thyroid cancer
Immature granulocyte count for thyroid malignancies
The correlation between DNI and thyroid cancer
Neutrophyl to lymphocyte ratio for thyroid malignancies
The correlation between DNI and thyroid cancer
Secondary Outcome Measures
Full Information
NCT ID
NCT04425512
First Posted
April 23, 2020
Last Updated
June 9, 2020
Sponsor
Kahramanmaras Sutcu Imam University
1. Study Identification
Unique Protocol Identification Number
NCT04425512
Brief Title
Delta Neutrophil Index and Neutrophil Lymphocyte Ratio in Thyroid Malignancy
Official Title
Delta Neutrophil Index and Neutrophil Lymphocyte Ratio in Differentiation of Thyroid Malignancy and Nodular Goiter
Study Type
Interventional
2. Study Status
Record Verification Date
June 2020
Overall Recruitment Status
Completed
Study Start Date
November 1, 2014 (Actual)
Primary Completion Date
November 1, 2019 (Actual)
Study Completion Date
November 1, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Kahramanmaras Sutcu Imam University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Thyroid surgery is the most common surgical procedure among endocrine surgeries. It is performed in patients with suspected malignancy, patients diagnosed with malignancy, and for toxic nodular goiter [1]. Fine-needle aspiration biopsy (FNAB) is used as a daily technique in preoperative evaluation to differentiate malignant and benign nodules. However, complications including hematoma formation, tumor transplantation along the needle trace, thyroid nodule infarction and vascular proliferation can be seen even in this minimally invasive procedure [2]. Therefore, the differentiation of benign and malignant groups using non-interventional methods before surgery has become important.
Cancer-related inflammation, including papillary thyroid carcinoma, is involved in carcinogenesis and progression of neoplastic disease [3,4]. Neutrophils induced by the tumor can accelerate tumor metastasis [3,5]. Lymphocytes, as the cornerstone of the adaptive immune system, inhibit tumor cell proliferation and migration as well as destroying metastases [3,6]. Previous studies have shown that increased lymphocyte count has a positive effect on better survival in patients with advanced cancer [7]. Furthermore, Kupffer cells, also known as liver macrophages, destroy circulating cancer cells and help the distribution of tumor cells via circulation. Therefore, routine blood tests have been investigated as a predictive or prognostic factor for carcinomas since blood parameters in these tests show whether there is inflammation. Neutrophil count, lymphocyte count, neutrophil-lymphocyte ratio (NLR), lymphocyte-monocyte ratio (LMR), mean platelet volume (MPV), and platelet distribution width (PDW) have been studied in terms of numerous malignancies [3].
Tumor-related inflammation is activated the bone marrow and inflammation induced by malignancies. Inflammatory activity that is poorly controlled or uncontrollable may be responsible for malignant transformation [8]. At this point, NLR has previously been shown to be useful in the differentiation of thyroid malignancies and benign thyroid diseases [9]. Delta neutrophil index (DNI) / increased number of immature granulocytes (IG) represents active bone marrow. Delta neutrophil index, which is manifested by IG formation in inflammatory and infectious events, shows changes in the white blood cell count [10].
This study aimed to evaluate the relation between the automatically calculated DNI/IG count and manually calculated NLR from the preoperative complete blood count (CB) parameters, and thyroid malignancies with a cost-effective non-invasive method before surgery or biopsy as the indicator of the malignant inflammatory response in the differentiation of nodular goiter and thyroid malignancy.
Detailed Description
Material-Methods Patients over the age of 18 who underwent thyroid surgery and who were operated on non-malignant benign causes (inguinal hernia) under selective conditions without any thyroid disease between November 2014 and November 2019 in Kahramanmaraş Sütçü İmam University Department of General Surgery were evaluated in this retrospective case-control cohort study. Patients in the thyroid pathology group (Group T) were divided into two subgroups according to their pathologic results: malignant (Group M) and benign thyroid disorders (Group B). Patients operated for inguinal hernia, were selected as control group (Group C).
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Preoperative biopsy results of patients undergoing FNAB in the preoperative period were investigated according to the Bethesda Classification System [11]. Neutrophil - lymphocyte count in the routine complete blood count (CBC) values, which were measured in the preoperative period and the postoperative sixth-month follow-ups, were recorded retrospectively and calculated manually. DNI (IG percentage) and IG counts were recorded from the values measured automatically in the CBC performed in the preoperative period and the postoperative sixth-month. Patient data were obtained from patient epicrisis forms and preoperative laboratory and postoperative pathology results recorded in the computer system.
Statistical Analysis The power analysis of the study was conducted with G-Power 3.0.10 programming system. Estimated power analysis and the sample size with an 0.8 power and effect size 0.1 according to three groups evaluation for 2 repeated measures in need of total 246 samples.
Statistical analysis was performed using IBM Social Package for the Social Sciences (SPSS) version 20 software. In the evaluation of independent groups, Kolmogorov-Smirnov and Shapiro-Wilk tests were used to determine if the distrubiton of variables were normal or not. Student t-test or Mann-Whitney U test was used to evaluate the numerical data between Group C and Group T. ANOVA or Kruskal Wallis test was used to evaluate numerical data for subgroup relations with Group C. Chi-square test or Fischer's exact test was used to evaluate categorical data. The repeated-measures ANOVA was used to evaluate the differences between the preoperative and postoperative periods. The data were evaluated using Posthoc Tukey's B test following the variance analysis. Sensitivity and specificity values and cut-off values were obtained via the receiver operating characteristic (ROC) analysis to evaluate the effectiveness of NLR, IG count, and DNI.
Numerical data were expressed as mean ± standard deviation (minimum-maximum values) or median (minimum-maximum values) according to the normal distribution. Categorical values were expressed as percentages (%).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Thyroid Cancer, Thyroid Nodule, Thyroid Diseases, Delta Neutrophyl Index, Immature Granulocyte Count, Neutrophyl to Lymphocyte Ratio
Keywords
Delta neutrophyl index, Immature granulocyte count, Thyroid Cancer, Thyroid Nodule, Neutrophyl to lymphocyte ratio
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
333 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Thyroid Malignancy
Arm Type
Active Comparator
Arm Description
Thyroidectomy
Arm Title
Benign Thyroidal Goitor
Arm Type
Sham Comparator
Arm Description
Thyroidectomy
Arm Title
Control Group
Arm Type
Other
Arm Description
Selective lichtenstein procedure for inguinal hernia
Intervention Type
Diagnostic Test
Intervention Name(s)
Complete Blood Count
Other Intervention Name(s)
Thyroidectomy
Intervention Description
Complete Blood Count samples
Primary Outcome Measure Information:
Title
Delta neutrophyl index for thyroid malignancies
Description
The correlation between DNI and thyroid cancer
Time Frame
retrospective 5 year
Title
Immature granulocyte count for thyroid malignancies
Description
The correlation between DNI and thyroid cancer
Time Frame
retrospective 5 year
Title
Neutrophyl to lymphocyte ratio for thyroid malignancies
Description
The correlation between DNI and thyroid cancer
Time Frame
retrospective 5 year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criterias:
Operated thyroid malignancy patients (Total thyrodectomy, complementary thyroidectomy)
Operated benign thyoridal goitor patients
Selectively operated inguinal hernia patients without any concomitant malignancy
Selectively operated inguinal hernia patients without any thyroid disorder
Exclusion Criterias:
Patients undergoing emergent surgery
Patients with concomitant rheumatologic disease undergoing thyroid surgery in selective conditions
Patients with concomitant rheumatologic disease undergoing inguinal hernia operation in selective conditions
Patients with concomitant thyroid disease undergoing inguinal hernia operation in selective conditions
Patients with concomitant any malignancy undergoing inguinal hernia operation in selective conditions
Patients whose data were not available or were missing.
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
Citation
Smith PW, Hanks LR, Salomonev LJ, Hanks JB. Sabiston's Text Book of Surgery 20th Edition, The Biological Basis of Modern Surgical Practice. 20th edition, Philedelphia/USA: Elsevier; 2017. Chapter 36 Thyroid. Pp: 881-922
Results Reference
background
PubMed Identifier
32041420
Citation
Madden LL, Nagatsuka M, Vasi AZ, Madrecha J, Smith LJ. Nerve Injury During Ultrasound-Guided Thyroid Biopsy-A First Reported Complication of Permanent Vocal Fold Paralysis. Ear Nose Throat J. 2021 Sep;100(5_suppl):663S-666S. doi: 10.1177/0145561320902855. Epub 2020 Feb 10.
Results Reference
background
PubMed Identifier
30241494
Citation
Wen W, Wu P, Li J, Wang H, Sun J, Chen H. Predictive values of the selected inflammatory index in elderly patients with papillary thyroid cancer. J Transl Med. 2018 Sep 21;16(1):261. doi: 10.1186/s12967-018-1636-y.
Results Reference
background
PubMed Identifier
11229684
Citation
Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001 Feb 17;357(9255):539-45. doi: 10.1016/S0140-6736(00)04046-0.
Results Reference
background
PubMed Identifier
27282249
Citation
Coffelt SB, Wellenstein MD, de Visser KE. Neutrophils in cancer: neutral no more. Nat Rev Cancer. 2016 Jul;16(7):431-46. doi: 10.1038/nrc.2016.52. Epub 2016 Jun 10.
Results Reference
background
PubMed Identifier
25050201
Citation
Bastid J, Bonnefoy N, Eliaou JF, Bensussan A. Lymphocyte-derived interleukin-17A adds another brick in the wall of inflammation-induced breast carcinogenesis. Oncoimmunology. 2014 Mar 27;3:e28273. doi: 10.4161/onci.28273. eCollection 2014.
Results Reference
background
PubMed Identifier
22318781
Citation
He JR, Shen GP, Ren ZF, Qin H, Cui C, Zhang Y, Zeng YX, Jia WH. Pretreatment levels of peripheral neutrophils and lymphocytes as independent prognostic factors in patients with nasopharyngeal carcinoma. Head Neck. 2012 Dec;34(12):1769-76. doi: 10.1002/hed.22008. Epub 2012 Feb 9.
Results Reference
background
PubMed Identifier
30588200
Citation
Lee F, Yang PS, Chien MN, Lee JJ, Leung CH, Cheng SP. An Increased Neutrophil-to-Lymphocyte Ratio Predicts Incomplete Response to Therapy in Differentiated Thyroid Cancer. Int J Med Sci. 2018 Nov 23;15(14):1757-1763. doi: 10.7150/ijms.28498. eCollection 2018.
Results Reference
background
PubMed Identifier
25987053
Citation
Kocer D, Karakukcu C, Karaman H, Gokay F, Bayram F. May the neutrophil/lymphocyte ratio be a predictor in the differentiation of different thyroid disorders? Asian Pac J Cancer Prev. 2015;16(9):3875-9. doi: 10.7314/apjcp.2015.16.9.3875.
Results Reference
background
PubMed Identifier
31065366
Citation
Kim TY, Kim SJ, Kim YS, Lee JW, Park EJ, Lee SJ, Lee KJ, Cha YS. Delta neutrophil index as an early predictive marker of severe acute pancreatitis in the emergency department. United European Gastroenterol J. 2019 May;7(4):488-495. doi: 10.1177/2050640619838359. Epub 2019 Mar 14.
Results Reference
background
PubMed Identifier
29091573
Citation
Cibas ES, Ali SZ. The 2017 Bethesda System for Reporting Thyroid Cytopathology. Thyroid. 2017 Nov;27(11):1341-1346. doi: 10.1089/thy.2017.0500.
Results Reference
background
Learn more about this trial
Delta Neutrophil Index and Neutrophil Lymphocyte Ratio in Thyroid Malignancy
We'll reach out to this number within 24 hrs